Oxygen therapy does not improve survival in patients with heart attack symptoms

August 28, 2017

Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-breaking research presented today in a Hot Line LBCT Session at ESC Congress and published in the NEJM.

"The DETO2X-AMI study questions the current practice of routine for all patients with suspected ( attack)," said first author Dr Robin Hofmann, a cardiologist from the Karolinska Institutet at Södersjukhuset, Stockholm, Sweden.

This prospective, randomised, open-label trial enrolled 6 229 patients with suspected heart attack from 35 hospitals across Sweden. Half of the patients were assigned to oxygen given through an open face mask and the other half to room air without a mask.

The primary outcome, the mortality rate one year after randomisation, was not statistically different between the two groups (5.0 percent in the oxygen group versus 5.1 percent in the air group). Similarly, there was no significant difference between the two groups for secondary endpoints, including the risk of a new heart attack or heart muscle injury measured by markers in the blood.

Even in patients at high risk, such as smokers, older patients, patients with diabetes, or patients with previous heart disease, the results were similar concerning mortality within one year.

European Society of Cardiology (ESC) guidelines on treatment of patients with ST-segment elevation myocardial infarction (STEMI) recommend oxygen (by mask or nasal prongs) for patients who are breathless, hypoxic, or have heart failure. (3) They add that the systematic use of oxygen in patients without heart failure or dyspnoea (shortness of breath) "is at best uncertain".

"ESC guidelines have gradually shifted towards more restrictive use of oxygen," said author Prof Stefan James, a cardiologist at Uppsala University, Uppsala, Sweden. "While the current recommendations were based on expert opinion only, we can now add substantial new data from our large clinical trial."

"The study results will likely have an immediate impact on clinical practice and future guidelines," he added. "Our findings do not support the routine use of oxygen therapy in all patients with symptoms of a . The general use of oxygen in these cases is still widespread in the world but can now be adjusted."

A fear that oxygen therapy could be harmful arose after the AVOID trial found a larger infarct size in patients receiving oxygen therapy. "Routine oxygen therapy seems unnecessary in this patient group, but fortunately our data do not give any indication of increased risk for the patients on oxygen," said Prof James. "So all of us who have generally used oxygen for decades can now rest assured."

The DETO2X-AMI trial is the first large-scale randomised trial of oxygen therapy in patients with suspected myocardial infarction to be large enough to reveal meaningful findings on mortality and morbidity. The study enrolled six times more patients than all previous randomised trials of this therapy combined and included a much broader range of patients to make the results relevant to everyday clinical practice.

The study's registry-based randomised clinical trial protocol used national registries including SWEDEHEART for randomisation, case record forms and follow-up. Dr Hofmann said: "With this design we could enrol 6 629 patients with high quality data in less than three years and keep overall costs to a fraction of a conventional randomised trial."

Explore further: TASTE trial finds no benefit of thrombus aspiration for AMI at one year

More information: Oxygen Therapy in Suspected Acute Myocardial Infarction. NEJM. DOI: 10.1056/NEJMoa1706222

Related Stories

TASTE trial finds no benefit of thrombus aspiration for AMI at one year

September 2, 2014
Thrombus aspiration for acute myocardial infarction (AMI) does not reduce mortality or other clinical endpoints long term, according to the awaited one-year follow-up results from the Thrombus Aspiration in ST- Elevation ...

Gender gap in death from heart attack reduces particularly in younger women

August 27, 2017
The gender gap in death from heart attack has reduced over the past two decades particularly in younger women, according to research presented today at ESC Congress. The study in over 50 000 patients found that overall in-hospital ...

No evidence to support giving oxygen to people having a heart attack, research shows

October 1, 2013
(Medical Xpress)—For 100 years inhaled oxygen has been a standard treatment for those with a suspected or confirmed heart attack. The latest research, was led by academics from City University London and the University ...

ESC Guidelines on ST-segment elevation myocardial infarction published today

August 26, 2017
European Society of Cardiology (ESC) Guidelines on the management of acute myocardial infarction in patients with ST-segment elevation are published online today in European Heart Journal, and on the ESC website.

Some heart attack patients may not benefit from beta blockers

May 29, 2017
New research challenges established medical practice that all heart attack patients should be on beta blockers.

TASTE trial challenge current practice of blood clot aspiration after heart attack

September 1, 2013
Aspiration of the blood clot or "thrombus" that causes a heart attack before re-opening a patient's artery with a balloon catheter does not improve survival compared to performing balloon dilation and stenting alone according ...

Recommended for you

Laser device placed on the heart identifies insufficient oxygenation better than other measures

September 20, 2017
A new device can assess in real time whether the body's tissues are receiving enough oxygen and, placed on the heart, can predict cardiac arrest in critically ill heart patients, report researchers at Boston Children's Hospital ...

Metabolism switch signals end for healing hearts

September 19, 2017
Researchers have identified the process that shuts down the human heart's ability to heal itself, and are now searching for a drug to reverse it.

Beta blockers not needed after heart attack if other medications taken

September 18, 2017
A new study from the University of North Carolina at Chapel Hill finds beta blockers are not needed after a heart attack if heart-attack survivors are taking ACE inhibitors and statins. The study is the first to challenge ...

Which single behavior best prevents high blood pressure?

September 15, 2017
(HealthDay)—You probably already know that certain healthy lifestyle behaviors can reduce your risk of developing high blood pressure, but is any one behavior more important than the others?

RESPECT trial shows closing a small hole in heart may protect against recurrent stroke

September 13, 2017
A device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk, according to the results of a large clinical trial ...

Study shows so-called 'healthy obesity' is harmful to cardiovascular health

September 11, 2017
Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities such as diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.